key: cord-0869580-y6o14jwt
authors: Kêdziora, Piotr; Stasiak, Aleksandra
title: Two Faces of Brugada Syndrome
date: 2022-05-04
journal: Indian Pediatr
DOI: 10.1007/s13312-022-2505-6
sha: d5f159dacdc130a4b0b630808202b4b3ddfd6330
doc_id: 869580
cord_uid: y6o14jwt

nan

nation revealed an uneven outline of the left coronary artery. In addition, moderate mitral, pulmonary, and tricuspid valves regurgitation were observed. An ECG recorded during an episode of fever revealed a 2-3 mm ST-T segment elevation, such as in Brugada syndrome type 1 (Fig. 2) . Treatment was done as per protocol including intravenous immunoglobulin, and later the child also received intravenous steroids. In control ECG exami-nations, including the examination with the V1 and V2 electro-des placed 1 and 2 intercostal spaces above the conventional site, no characteristic features of Brugada syndrome were found. A gradual improvement in the clinical condition and normalization of laboratory parameters were observed. Resting ECGs of the patient's immediate family were normal. Patient was instructed with preventive recommen-dations as in Brugada syndrome. The boy was directed for genetic testing and he remains under cardiology follow-up.

The diagnosis of Brugada syndrome can be set after recording the characteristic morphology in lead V1 and/or V2 (or after switching these electrodes to the 2nd, 3rd intercostal spacenominal or high leads) during resting ECG spontaneously or after a drug provocation test (intravenous administration of a sodium channel blocking drug) [3] . Cardiac arrest is most often preceded by symptoms, such as: heart palpitations, syncope, and breathlessness at night. The disease is 8-times more common in males. Several genes are responsible for the disease, the most common mutations are associated with SCN5A gene, and several pathogenic variants are described. However, experts disagree on the usefulness of genetic testing. In AHA/ACC/HRS 2017 guide-lines, it is mentioned that ''genetic testing may be useful in the diagnosis and care of relatives of people with Brugada syndrome.''

In asymptomatic patients diagnosed with Brugada syndrome, it is recommended to avoid drugs contraindicated in Brugada syndrome, strictly prohibit the consumption of alcohol and psychoactive substances, avoid fever, avoid heavy meals, monitor vital parameter (mainly at night) [2] . Several adult patients have been described in whom the resting ECG during the acute phase of SARS-CoV-2 disease revealed abnormalities of repolarization suggestive of Brugada syndrome, though all had fever and ionic disturbances [3] [4] [5] . In most patients, ECG changes normalized spontaneously after resolution of fever and did not cause serious ventricular arrhythmias. Our second patient had several risk factors that could have led to Brugada-like changes in ECG, including fever, ionic disturbances (hyponatremia, hypophosphatemia), as well as damage to the myocardium itself in the course of PIMS-TS syndrome (i.e., changes in the coronary arteries) with negative family history [5] [6] [7] .

The spectrum of neurological conditions associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is evolving. Here, we describe a case of N-methyl-D-aspartate receptor encephalitis (NMDAR-E) with possible temporal association with SARS-CoV-2.

A 10-month-old typically developing boy presented with poor feeding and irritability for 5 days. On day 3 of illness, he developed fever and loose stools with 2 episodes of convulsions on day 5 of illness, when he was brought to our hospital. It was associated with loss of pre-morbidly normal eye contact. He had an upper respiratory tract infection (URTI) 40 days prior to illness onset. At presentation, his axillary temperature was 98.2 0 F, pulse rate was 92/minute, respiratory rate was 24/minute and blood pressure was 84/54 mmHg. General physical and systemic examinations were unremarkable. On neurological examination, baby was not interested in surroundings and had poor interaction with caregivers. Cranial nerve examination was unremarkable. Motor system examination revealed normal power and tone, with brisk deep tendon reflexes. Peri-oral dyskinesias and bilateral striatal toe were present. Cerebellar and meningeal signs were absent. In view of fever, diarrhea, seizures, acute onset encephalopathy with extrapyramidal movements, possibilities considered at admission were post-infectious immune-mediated conditions (central nervous system demyelination, autoimmune encephalitis, post-COVID multisystem inflammatory syndrome (MIS-C)) and inherited metabolic disorder. Prior to referral, baby had a normal cerebrospinal fluid (CSF) study and C-reactive protein (CRP) with elevated white cell count (WBC, 26×10 9 /L). Initial investigations at our center revealed elevated WBC (24 ×10 9 /L, N61L30), normal CRP (1 mg/L) and procalcitonin (0.25 ng/mL). SARS-CoV-2 IgG antibodies were strongly positive (index-20.7, >1.0 positive). Erythrocyte sedimentation rate (22 mm/first hour), lactate dehydrogenase (515 U/L), ferritin (19.5 ng/ mL) and echocardiography (normal) were not consistent with MIS-C.

Over the next 24 hours, extrapyramidal movements worsened with appearance of generalized and oro-linguo-buccal dystonia with athetosis. Hence, possibility of anti-NMDA encephalitis was considered. MRI brain was normal. CSF showed 20 cells (95%L), sugar 65 mg/ dL (blood sugar: 102 mg/dL), protein 27 mg/ dL. CSF-polymerase chain reaction (PCR) was negative (Eschershia coli K1, Hemophlilus influenzae, Listeria monocytogenes, Streptococcus agalactiae, Streptococcus pneumonia, Cytomegalovirus, enterovirus, HSV1, HSV2, HHV6, Human parechovirus, Varicella zoster virus and Crypto-coccus neoformans/gatii). CSF sample for NMDA antibodies was sent to the laboratory.

Child was started on intravenous immunoglobulin (2 g/kg) and pulse methylprednisolone (30 mg/kg/day for 5 days) on day 8 of illness. CSF sample was reported strongly positive for anti-NMDA antibodies (indirect immunofluorescence assay). Computed tomography (CT) of abdomen and pelvis for tumor screening was negative. By day 5 of pulse steroids, there was no improvement in extrapyramidal movements or encephalopathy. Considering severe infantile form of anti-NMDAR encephalitis poorly responsive to first line therapy, weekly rituximab infusion (375 mg/m 2 /dose/week for 4 doses) was initiated in the second week of illness, along with addition of azathioprine for long-term immunosuppression (2 mg/kg/day). Two weeks after last rituximab dose, baby remained encephalopathic. Extrapyramidal movements were partially controlled with clonidine, baclofen and clonazepam. In view of refractory disease, monthly cyclophos-

implantable cardioverter-defibrillators in children and adolescents with Brugada syndrome

The definition of Brugada syndrome

The diagnostic yield of Brugada syndrome after sudden death with normal autopsy

Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Electrocardiographic manifestations of COVID-19

Transient Brugada-like electrocardiographic pattern in a patient with COVID-19

Two patients with COVID-19 and a fever-induced Brugada-like electrocardiographic pattern

COVID-19 infection unmasking Brugada syndrome